End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: Presentation, survival and prognostic factors

Amyloid

Volumn 11, Issue 1, 2004, Pages 27-37

  Lobato, Luísa ^a,b,c   Beirão, Idalina ^a,c   Silva, Manuela ^a   Fonseca, Isabel ^a   Queirós, José ^a   Rocha, Guilherme ^a   Sarmento, Antonio Morais ^a   Sousa, Aida ^b,c,d   Sequeiros, Jorge ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Centro de Estudos de Paramiloidose   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Amyloidosis; Dialysis; End stage renal disease; Familial; Kidney; Neuropathy; Survival; Transthyretin

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DECUBITUS; DISABILITY; DISEASE COURSE; EYE DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INTRAVENOUS CATHETER; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROSIS; NEUROGENIC BLADDER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN VARIANT; PROTEINURIA; SEPSIS; SKIN INJURY; SURVIVAL TIME; URINARY TRACT INFECTION; VASCULAR ACCESS;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; RENAL DIALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 2542488594     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120410001673884     Document Type: Article

References (36)

1. Gertz MA, Kyle RA, O'Fallon WM (1992). Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152, 2245-2250
2. Martinez-Vea A, Garcia C, Carreras M, Revert L, Oliver JA (1990). End-stage renal disease in systemic amyloidosis: Clinical course and outcome on dialysis. Am J Nephrol 10, 283-289
3. Moroni G, Banfi G, Montoli A, Bucci A, Bertani T, Ravelli M, Pozzi C, Leonelli M, Lupo A, Volpi A, Pasquali S, Salvadeo A (1992). Chronic dialysis in patients with systemic amyloidosis: The experience of northern Italy. Clin Nephrol 38, 81-85
4. Cantaluppi A (1988). CAPD and systemic diseases. Clin Nephrol 30, S8-S12
5. Choukroun G, Goupy CH Noël LH, Droz D, Grünfeld JP (2000). Amylose du rein et de l'appareil urinaire. In Grateau G, Benson MD, and Delpech M (eds.) Les Amyloses, pp 163-177 (Médecine-Sciences Flammarion, Paris)
6. Merlini G (1995). Treatment of primary amyloidosis. Semin Hematol 32, 60-79
7. Tan SY, Pepys MB, Hawkins PN (1995). Treatment of amyloidosis. Am J Kidney Dis 26, 267-285
8. Saraiva MJM (2001). Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 17, 493-503
9. Andrade C (1952). A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with specifical involvement of the peripheral nerves. Brain 75, 408-427
10. Sousa A, Coelho T, Morgado R, Coutinho P (1990). Statistical analysis of factors which may influence the duration of familial amyloidotic polyneuropathy type I. In Costa PP, Falcão de Freitas A, and Saraiva MJ (eds). Familial Amyloidotic Polyneuropahty and Other Transthyretin Related Disorders, pp. 351-355 (Arquivos de Medicina, Porto)
11. Lobato L, Beirão B, Guimarães SM, Droz D, Guimarães S, Grünfeld JP, Noël LH (1998). Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am J Kidney Dis 6, 940-946
12. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB (1993). Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341, 1113-1116
13. Suhr O, Holmgren G, Steen L, Wikström L, Norden G, Frimean S, Duraj FF, Groth CG, Ericzon BG (1995). Liver transplantation in familial amyloidotic polyneuropathy: follow-up of the first 20 Swedish patients. Transplantation 60, 933-938
14. Cockcroft DW, Gault MH (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-35
15. Beirão I, Lobato L, Silva M, Coelho T, Xavier E, Guimarães S (1996). Clinical course and outcome in Patients with FAP TTR Met 30 on regular hemodialysis. Neuromuscular Disord 8, 56
16. Fonseca I, Lobato L, Deirão I, Guimarães S (1999). Nutritional support in familial amyloidotic polyneuropathy type I patients. In Robert A Kyle and Morie Gertz (eds) Amyloid and Amyloidosis pp. 291-293 (The Parthenon Publishing Group, USA)
17. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O (1993). Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset and prevalence. Hum Hered 43, 288-294
18. US Renal Data System: Excerpts from the USRDS 2001 Annual Data Report (2001). Am J Kidney Disease 38 (Suppl 3), S1-S248
19. Carvalho M, Conceição I, Bentes C, Sales Luís ML (2002). Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid: J Protein Folding Disord 9, 126-133
20. Carvalho MJ, Lobato L, Ventura A, Beirão I, Rocha G, Seca R, Miranda HP, Silvestre F, Pereira MC, Guimarães S (2000). Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR Met30. Transplant Proc 32, 2664-2666
21. Tashima K, Ando Y, Ando E, Tanaka Y, Ando M, Uchino M (1997). Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP TTR Met30). Amyloid: Int J Exp Clin Invest 4, 108-111
22. Maciel L, Carvalho MJ, Cotter J, Freitas J, Mota JC, Puig J, Falcão de Freitas A (1990). The heart in familial amyloidotic polyneuropathy: an overview. In Costa PP, Falcão de Freitas A, and Saraiva MJ (eds). Familial Amyloidotic Polyneuropahty and Other Transthyretin Related Disorders, pp. 285-289 (Arquivos de Medicina, Porto)
23. Olofsson BO, Backman C, Karp K, Suhr O (2002). Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 73, 745-751
24. Hüting J, Kramer W, Reittinger J, Kuhn K, Wizeman V, Schutterle G (1990). Cardiac structure and function in continuous ambulatory peritoneal dialysis: influence of blood purification and hypercirculation. Am Heart J 119, 334-352
25. Furtado D, Gonçalves A, Carvalho O (1952). Paramiloidose de forma nevrítica. Jornal do Médico XX, 977-983
26. Keven K, Öztas E, Aksoy H, Duman N, Erbay B, Ertürk Ş (2001). Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever. Am J Kidney Dis 38, E39
27. Avram MM, Mittman N, Myint MM, Fein P (2001). Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal patients: 14 years of prospective observation. Am J Kidney Dis 38, 1351-1357
28. Ning J, Sun M, Ikeda T (1999). Relationship between hypotension during hemodyalysis and autonomie dysfunction in diabetic hemodialysis patients. Hum Yi Ke Xue Xue Bao 24, 572-574
29. Zocalli C, Mallanci F, Tripepi G, Benedetto FA (2001). Autonomie neuropathy is linked to nocturnal hypoxaemia and concentric hypertrophy and remodeling in dialysis patients. Nephrol Dial Transplant 16, 10-77
30. Besarab A, Raja RM (2001). Vascular access for dialysis. In J Daugirdas, PG Blake, TS Ing (eds). Handbook of Dialysis, pp 67-101 (Philadelphia: Lippincott Williams & Wilkins)
31. Hezemans RL, Krediet RT, Arisz L (1995). Dialysis treatment in patients with rheumatoid arthritis. Neth J Med 47, 6-11
32. Lowrie EG, Lew NL (1990). Death risk in hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 15, 458-482
33. Churchill DN (1997). An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 30, 899-906
34. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H (1992). Canadian hemodialysis morbidity study. Am J Kidney Dis 19, 214-234
35. Gertz MA, Lacy MQ, Dispenzieri A (2002). Immunoglobulin light chain amyloidosis and the kidney. Kidney Int 61, 1-9
36. Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B (1992). Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol, Dial and Transplant 7, 908-912